Carboxylesterases are uniquely expressed among tissues and regulated by nuclear hormone receptors in the mouse

Ryan D. Jones, Anna M. Taylor, Ernest Y. Tong, Joyce J. Repa

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Carboxylesterases (CES) are a well recognized, yet incompletely characterized family of proteins that catalyze neutral lipid hydrolysis. Some CES have well-defined roles in xenobiotic clearance, pharmacologic prodrug activation, and narcotic detoxification. In addition, emerging evidence suggests other CES may have roles in lipid metabolism. Humans have six CES genes, whereas mice have 20 Ces genes grouped into five isoenzyme classes. Perhaps due to the high sequence similarity shared by the mouse Ces genes, the tissue-specific distribution of expression for these enzymes has not been fully addressed. Therefore, we performed studies to provide a comprehensive tissue distribution analysis of mouse Ces mRNAs. These data demonstrated that while the mouse Ces family 1 is highly expressed in liver and family 2 in intestine, many Ces genes have a wide and unique tissue distribution defined by relative mRNA levels. Furthermore, evaluating Ces gene expression in response to pharmacologic activation of lipid- and xenobiotic-sensing nuclear hormone receptors showed differential regulation. Finally, specific shifts in Ces gene expression were seen in peritoneal macrophages following lipopolysaccharide treatment and in a steatotic liver model induced by high-fat feeding, two model systems relevant to disease. Overall these data show that each mouse Ces gene has its own distinctive tissue expression pattern and suggest that some CES may have tissue-specific roles in lipid metabolism and xenobiotic clearance.

Original languageEnglish (US)
Pages (from-to)40-49
Number of pages10
JournalDrug Metabolism and Disposition
Volume41
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Carboxylic Ester Hydrolases
Cytoplasmic and Nuclear Receptors
Xenobiotics
Tissue Distribution
Genes
Lipid Metabolism
Lipids
Gene Expression
Messenger RNA
Liver
Narcotics
Prodrugs
Peritoneal Macrophages
Isoenzymes
Intestines
Lipopolysaccharides
Hydrolysis
Fats
Enzymes
Proteins

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Carboxylesterases are uniquely expressed among tissues and regulated by nuclear hormone receptors in the mouse. / Jones, Ryan D.; Taylor, Anna M.; Tong, Ernest Y.; Repa, Joyce J.

In: Drug Metabolism and Disposition, Vol. 41, No. 1, 01.2013, p. 40-49.

Research output: Contribution to journalArticle

@article{363c617720894c3f9af6207d2d84e4d2,
title = "Carboxylesterases are uniquely expressed among tissues and regulated by nuclear hormone receptors in the mouse",
abstract = "Carboxylesterases (CES) are a well recognized, yet incompletely characterized family of proteins that catalyze neutral lipid hydrolysis. Some CES have well-defined roles in xenobiotic clearance, pharmacologic prodrug activation, and narcotic detoxification. In addition, emerging evidence suggests other CES may have roles in lipid metabolism. Humans have six CES genes, whereas mice have 20 Ces genes grouped into five isoenzyme classes. Perhaps due to the high sequence similarity shared by the mouse Ces genes, the tissue-specific distribution of expression for these enzymes has not been fully addressed. Therefore, we performed studies to provide a comprehensive tissue distribution analysis of mouse Ces mRNAs. These data demonstrated that while the mouse Ces family 1 is highly expressed in liver and family 2 in intestine, many Ces genes have a wide and unique tissue distribution defined by relative mRNA levels. Furthermore, evaluating Ces gene expression in response to pharmacologic activation of lipid- and xenobiotic-sensing nuclear hormone receptors showed differential regulation. Finally, specific shifts in Ces gene expression were seen in peritoneal macrophages following lipopolysaccharide treatment and in a steatotic liver model induced by high-fat feeding, two model systems relevant to disease. Overall these data show that each mouse Ces gene has its own distinctive tissue expression pattern and suggest that some CES may have tissue-specific roles in lipid metabolism and xenobiotic clearance.",
author = "Jones, {Ryan D.} and Taylor, {Anna M.} and Tong, {Ernest Y.} and Repa, {Joyce J.}",
year = "2013",
month = "1",
doi = "10.1124/dmd.112.048397",
language = "English (US)",
volume = "41",
pages = "40--49",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Carboxylesterases are uniquely expressed among tissues and regulated by nuclear hormone receptors in the mouse

AU - Jones, Ryan D.

AU - Taylor, Anna M.

AU - Tong, Ernest Y.

AU - Repa, Joyce J.

PY - 2013/1

Y1 - 2013/1

N2 - Carboxylesterases (CES) are a well recognized, yet incompletely characterized family of proteins that catalyze neutral lipid hydrolysis. Some CES have well-defined roles in xenobiotic clearance, pharmacologic prodrug activation, and narcotic detoxification. In addition, emerging evidence suggests other CES may have roles in lipid metabolism. Humans have six CES genes, whereas mice have 20 Ces genes grouped into five isoenzyme classes. Perhaps due to the high sequence similarity shared by the mouse Ces genes, the tissue-specific distribution of expression for these enzymes has not been fully addressed. Therefore, we performed studies to provide a comprehensive tissue distribution analysis of mouse Ces mRNAs. These data demonstrated that while the mouse Ces family 1 is highly expressed in liver and family 2 in intestine, many Ces genes have a wide and unique tissue distribution defined by relative mRNA levels. Furthermore, evaluating Ces gene expression in response to pharmacologic activation of lipid- and xenobiotic-sensing nuclear hormone receptors showed differential regulation. Finally, specific shifts in Ces gene expression were seen in peritoneal macrophages following lipopolysaccharide treatment and in a steatotic liver model induced by high-fat feeding, two model systems relevant to disease. Overall these data show that each mouse Ces gene has its own distinctive tissue expression pattern and suggest that some CES may have tissue-specific roles in lipid metabolism and xenobiotic clearance.

AB - Carboxylesterases (CES) are a well recognized, yet incompletely characterized family of proteins that catalyze neutral lipid hydrolysis. Some CES have well-defined roles in xenobiotic clearance, pharmacologic prodrug activation, and narcotic detoxification. In addition, emerging evidence suggests other CES may have roles in lipid metabolism. Humans have six CES genes, whereas mice have 20 Ces genes grouped into five isoenzyme classes. Perhaps due to the high sequence similarity shared by the mouse Ces genes, the tissue-specific distribution of expression for these enzymes has not been fully addressed. Therefore, we performed studies to provide a comprehensive tissue distribution analysis of mouse Ces mRNAs. These data demonstrated that while the mouse Ces family 1 is highly expressed in liver and family 2 in intestine, many Ces genes have a wide and unique tissue distribution defined by relative mRNA levels. Furthermore, evaluating Ces gene expression in response to pharmacologic activation of lipid- and xenobiotic-sensing nuclear hormone receptors showed differential regulation. Finally, specific shifts in Ces gene expression were seen in peritoneal macrophages following lipopolysaccharide treatment and in a steatotic liver model induced by high-fat feeding, two model systems relevant to disease. Overall these data show that each mouse Ces gene has its own distinctive tissue expression pattern and suggest that some CES may have tissue-specific roles in lipid metabolism and xenobiotic clearance.

UR - http://www.scopus.com/inward/record.url?scp=84871584504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871584504&partnerID=8YFLogxK

U2 - 10.1124/dmd.112.048397

DO - 10.1124/dmd.112.048397

M3 - Article

C2 - 23011759

AN - SCOPUS:84871584504

VL - 41

SP - 40

EP - 49

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 1

ER -